Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen ...

Waterdrop Inc. ("Waterdrop", the "Company" or "we") , a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial ...

Kinase inhibitors are very efficacious drugs for ... combined with diverse kinase-targeted libraries and high-throughput structure determination, will facilitate the discovery of selective ...

College of Pharmacy & Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Korea College of Pharmacy, CHA University, Pocheon, 487-010, Korea ...

Normally, filtered glucose is about 125 mg/min. Main action of SGLT2 inhibitors is the induction of glucosuria and osmotic diuresis. SGLT2 inhibitors reduce effectively fasting and postprandial ...

SGLT2 inhibitors are a new family of agents ... 2.4/CANA100 mg: 3.1/PL: 0 eGFR (mL/min/1.73 m 2):/CANA300 mg: −3.9/CANA100 mg: −3.6/PL: −1.4 eGFR (percentage changes %):/CANA300 mg: − ...

Medicinal Chemistry, Oncology, R&D, Acerta Pharma B.V., A member of the AstraZeneca Group, Oss 5349 AB, The Netherlands ...

The B-cell receptor of primary mouse B cells can be engineered to affinity mature an HIV-1-entry inhibitor in vivo. Modular synthetic G-protein-coupled receptors with nanobody-based ligand ...

Researchers at Inventisbio Co. Ltd. and Inventisbio LLC have described Werner syndrome ATP-dependent helicase (WRN; RECQ3; RECQL2) inhibitors reported to be useful for the treatment of cancer.